Is NKTX or NRSN more undervalued in 2026?

CirclFi compares Nkarta, Inc. (NKTX) and NeuroSense Therapeutics Ltd. (NRSN) using 13 institutional-grade valuation models. NKTX has a Quality of Company score of 4.6/10 while NRSN scores 3.8/10.

Which is a better buy — NKTX or NRSN?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do NKTX and NRSN valuations compare?

NKTX at $3.30 and NRSN at $0.86 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

NKTX vs NRSN Valuation Comparison 2026 — Intrinsic Value Analysis

NKTX

Biotechnology

Nkarta, Inc.

Quality

4.6

out of 10

Value Trap

SAFE

Price

$3.30

Last close

Models

7/13

Active

NRSN

Biotechnology

NeuroSense Therapeutics Ltd.

Quality

3.8

out of 10

Value Trap

SAFE

Price

$0.86

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	NKTX Fair Value	NKTX Upside	NRSN Fair Value	NRSN Upside
Bayesian DCF	Intrinsic	$0.66	-80.0%	$0.24	-72.5%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$2.32	-29.6%	$0.21	-75.4%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for NKTX vs NRSN — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

NKTX vs NRSN — Which Stock Is More Undervalued?

NKTX scores higher with a 4.6/10 quality rating vs NRSN's 3.8/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Nkarta, Inc. (NKTX) and NeuroSense Therapeutics Ltd. (NRSN) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

NKTX currently trades at $3.30 with a QOC of 4.6/10, while NRSN trades at $0.86 with a QOC of 3.8/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).